304 related articles for article (PubMed ID: 29105742)
1. Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders.
Foulk B; Schaffer M; Gross S; Rao C; Smirnov D; Connelly MC; Chaturvedi S; Reddy M; Brittingham G; Mata M; Repollet M; Rojas C; Auclair D; DeRome M; ; Weiss B; Sasser AK
Br J Haematol; 2018 Jan; 180(1):71-81. PubMed ID: 29105742
[TBL] [Abstract][Full Text] [Related]
2. Deep sequencing reveals myeloma cells in peripheral blood in majority of multiple myeloma patients.
Vij R; Mazumder A; Klinger M; O'Dea D; Paasch J; Martin T; Weng L; Park J; Fiala M; Faham M; Wolf J
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):131-139.e1. PubMed ID: 24629890
[TBL] [Abstract][Full Text] [Related]
3. Imaging flow cytometric detection of del(17p) in bone marrow and circulating plasma cells in multiple myeloma.
Mincherton TI; Lam SJ; Clarke SE; Hui HYL; Malherbe JAJ; Chuah HS; Sidiqi MH; Fuller KA; Erber WN
Int J Lab Hematol; 2024 Jun; 46(3):495-502. PubMed ID: 38379463
[TBL] [Abstract][Full Text] [Related]
4. Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma.
Wang N; Tesfaluul N; Li J; Gao X; Liu S; Yue B
Ann Hematol; 2019 Dec; 98(12):2769-2780. PubMed ID: 31748925
[TBL] [Abstract][Full Text] [Related]
5. Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).
Sanoja-Flores L; Flores-Montero J; Garcés JJ; Paiva B; Puig N; García-Mateo A; García-Sánchez O; Corral-Mateos A; Burgos L; Blanco E; Hernández-Martín J; Pontes R; Díez-Campelo M; Millacoy P; Rodríguez-Otero P; Prosper F; Merino J; Vidriales MB; García-Sanz R; Romero A; Palomera L; Ríos-Tamayo R; Pérez-Andrés M; Blanco JF; González M; van Dongen JJM; Durie B; Mateos MV; San-Miguel J; Orfao A;
Blood Cancer J; 2018 Nov; 8(12):117. PubMed ID: 30455467
[TBL] [Abstract][Full Text] [Related]
6. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of circulating clonal plasma cells in newly diagnosed multiple myeloma.
Han W; Jin Y; Xu M; Zhao SS; Shi Q; Qu X; Zhang R; Li J; Wu Y; Chen L
Hematology; 2021 Dec; 26(1):510-517. PubMed ID: 34314294
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.
Granell M; Calvo X; Garcia-Guiñón A; Escoda L; Abella E; Martínez CM; Teixidó M; Gimenez MT; Senín A; Sanz P; Campoy D; Vicent A; Arenillas L; Rosiñol L; Sierra J; Bladé J; de Larrea CF;
Haematologica; 2017 Jun; 102(6):1099-1104. PubMed ID: 28255016
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma.
Johnsen HE; Bøgsted M; Klausen TW; Gimsing P; Schmitz A; Kjaersgaard E; Damgaard T; Voss P; Knudsen LM; Mylin AK; Nielsen JL; Björkstrand B; Gruber A; Lenhoff S; Remes K; Dahl IM; Fogd K; Dybkaer K; ;
Cytometry B Clin Cytom; 2010 Sep; 78(5):338-47. PubMed ID: 20533391
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
[TBL] [Abstract][Full Text] [Related]
11. [Detection of circulating and bone marrow myeloma cells in patients with multiple myeloma and its clinical significance].
Jiang YQ; Li JY; Wu YJ; Yang H; Shen YF; Chen LJ; Xu W; Qian SX; Wu HX; Lu H; Shen RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):908-12. PubMed ID: 17096887
[TBL] [Abstract][Full Text] [Related]
12. High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.
Bianchi G; Kyle RA; Larson DR; Witzig TE; Kumar S; Dispenzieri A; Morice WG; Rajkumar SV
Leukemia; 2013 Mar; 27(3):680-5. PubMed ID: 22902364
[TBL] [Abstract][Full Text] [Related]
13. Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma.
Witzig TE; Kyle RA; O'Fallon WM; Greipp PR
Br J Haematol; 1994 Jun; 87(2):266-72. PubMed ID: 7947266
[TBL] [Abstract][Full Text] [Related]
14. The potential diagnostic power of CD138+ microparticles from the plasma analysis for multiple myeloma clinical monitoring.
Liu ZY; Tian MY; Deng L; Wang YS; Xing R; Liu H; Fu R
Hematol Oncol; 2019 Oct; 37(4):401-408. PubMed ID: 31291481
[TBL] [Abstract][Full Text] [Related]
15. Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.
Nowakowski GS; Witzig TE; Dingli D; Tracz MJ; Gertz MA; Lacy MQ; Lust JA; Dispenzieri A; Greipp PR; Kyle RA; Rajkumar SV
Blood; 2005 Oct; 106(7):2276-9. PubMed ID: 15961515
[TBL] [Abstract][Full Text] [Related]
16. Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression.
Gonsalves WI; Rajkumar SV; Dispenzieri A; Dingli D; Timm MM; Morice WG; Lacy MQ; Buadi FK; Go RS; Leung N; Kapoor P; Hayman SR; Lust JA; Russell SJ; Zeldenrust SR; Hwa L; Kourelis TV; Kyle RA; Gertz MA; Kumar SK
Leukemia; 2017 Jan; 31(1):130-135. PubMed ID: 27457702
[TBL] [Abstract][Full Text] [Related]
17. Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation.
Chakraborty R; Muchtar E; Kumar SK; Jevremovic D; Buadi FK; Dingli D; Dispenzieri A; Hayman SR; Hogan WJ; Kapoor P; Lacy MQ; Leung N; Gertz MA
Haematologica; 2017 Aug; 102(8):1439-1445. PubMed ID: 28473618
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
Hillengass J; Moehler T; Hundemer M
Recent Results Cancer Res; 2011; 183():113-31. PubMed ID: 21509683
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB
Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating monoclonal lymphocytes in multiple myeloma patients by analysis of gene rearrangements: correlation with progressive disease.
Knauf WU; Pochanke G; Ho AD
Leuk Res; 1993 Apr; 17(4):341-5. PubMed ID: 8487582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
